Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dissecting the multiple myeloma-bone microenvironment reveals new therapeutic opportunities
Authors
Keywords
Multiple myeloma, Bone microenvironment, Therapeutic opportunities
Journal
JOURNAL OF MOLECULAR MEDICINE-JMM
Volume 94, Issue 1, Pages 21-35
Publisher
Springer Nature
Online
2015-10-01
DOI
10.1007/s00109-015-1345-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Smoldering multiple myeloma
- (2015) S. V. Rajkumar et al. BLOOD
- Development of extramedullary myeloma in the era of novel agents: no evidence of increased risk with lenalidomide-bortezomib combinations
- (2015) Cindy Varga et al. BRITISH JOURNAL OF HAEMATOLOGY
- Mast Cells Influence the Proliferation Rate of Myeloma Plasma Cells
- (2015) Constantina A. Pappa et al. CANCER INVESTIGATION
- CSF-1/CSF-1R targeting agents in clinical development for cancer therapy
- (2015) Carola H Ries et al. CURRENT OPINION IN PHARMACOLOGY
- Ex Vivo–expanded Natural Killer Cells Demonstrate Robust Proliferation In Vivo in High-risk Relapsed Multiple Myeloma Patients
- (2015) Susann Szmania et al. JOURNAL OF IMMUNOTHERAPY
- Multiple Myeloma: New Uses for Available Agents, Excitement for the Future
- (2015) Kenneth C. Anderson Journal of the National Comprehensive Cancer Network
- Potent anti-tumor response by targeting B cell maturation antigen (BCMA) in a mouse model of multiple myeloma
- (2015) Felix Oden et al. Molecular Oncology
- Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma
- (2015) Michael G. Alexandrakis et al. PATHOLOGY & ONCOLOGY RESEARCH
- Immunomodulatory molecule PD-L1 is expressed on malignant plasma cells and myeloma-propagating pre-plasma cells in the bone marrow of multiple myeloma patients
- (2015) S Yousef et al. Blood Cancer Journal
- Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation
- (2015) Lavinia Raimondi et al. Oncotarget
- Tumoricidal Effects of Macrophage-Activating Immunotherapy in a Murine Model of Relapsed/Refractory Multiple Myeloma
- (2015) J. L. Jensen et al. Cancer Immunology Research
- Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms
- (2015) Jahangir Abdi et al. Oncotarget
- Multiple myeloma cells recruit tumor-supportive macrophages through the CXCR4/CXCL12 axis and promote their polarization toward the M2 phenotype
- (2015) Katia Beider et al. Oncotarget
- Myeloid-derived suppressor cell heterogeneity in human cancers
- (2014) Samantha Solito et al. Annals of the New York Academy of Sciences
- Osteoblastic niche supports the growth of quiescent multiple myeloma cells
- (2014) Z. Chen et al. BLOOD
- How I treat smoldering multiple myeloma
- (2014) I. M. Ghobrial et al. BLOOD
- Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti-IL-6) in multiple myeloma
- (2014) J. San-Miguel et al. BLOOD
- Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells
- (2014) J. Wang et al. BLOOD
- The skinny on obesity and plasma cell myeloma: a review of the literature
- (2014) K R Carson et al. BONE MARROW TRANSPLANTATION
- A Phase IB multicentre dose-determination study of BHQ880 in combination with anti-myeloma therapy and zoledronic acid in patients with relapsed or refractory multiple myeloma and prior skeletal-related events
- (2014) Swaminathan P. Iyer et al. BRITISH JOURNAL OF HAEMATOLOGY
- Integrating new discoveries into the “vicious cycle” paradigm of prostate to bone metastases
- (2014) Leah M. Cook et al. CANCER AND METASTASIS REVIEWS
- Bone marrow vascular niche and the control of angiogenesis in multiple myeloma
- (2014) Domenico Ribatti Frontiers in Bioscience-Landmark
- The bone marrow of myeloma patients is steadily inhabited by a normal-sized pool of functional regulatory T cells irrespectiveof the disease status
- (2014) M. Foglietta et al. HAEMATOLOGICA
- Diet-induced obesity promotes a myeloma-like condition in vivo
- (2014) S T Lwin et al. LEUKEMIA
- PKA/AMPK signaling in relation to adiponectin’s antiproliferative effect on multiple myeloma cells
- (2014) E A Medina et al. LEUKEMIA
- Targeting Immune Suppression with PDE5 Inhibition in End-Stage Multiple Myeloma
- (2014) K. A. Noonan et al. Cancer Immunology Research
- Adipose tissue and adipocytes support tumorigenesis and metastasis
- (2013) Kristin M. Nieman et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Tumor cells in multiple myeloma patients inhibit myeloma-reactive T cells through carcinoembryonic antigen-related cell adhesion molecule-6
- (2013) M. Witzens-Harig et al. BLOOD
- T cells expressing CD123-specific chimeric antigen receptors exhibit specific cytolytic effector functions and antitumor effects against human acute myeloid leukemia
- (2013) A. Mardiros et al. BLOOD
- Heparanase inhibits osteoblastogenesis and shifts bone marrow progenitor cell fate in myeloma bone disease
- (2013) Jian Ruan et al. BONE
- Immature dendritic cells in multiple myeloma are prone to osteoclast-like differentiation through interleukin-17A stimulation
- (2013) Marco Tucci et al. BRITISH JOURNAL OF HAEMATOLOGY
- Osteoclast-Derived Coupling Factors in Bone Remodeling
- (2013) Kim Henriksen et al. CALCIFIED TISSUE INTERNATIONAL
- A Phase I, Open-Label Study of Siltuximab, an Anti-IL-6 Monoclonal Antibody, in Patients with B-cell Non-Hodgkin Lymphoma, Multiple Myeloma, or Castleman Disease
- (2013) R. Kurzrock et al. CLINICAL CANCER RESEARCH
- Tumour-associated macrophages and cancer
- (2013) Jenny Cook et al. CURRENT OPINION IN PHARMACOLOGY
- Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration
- (2013) Ida B. Kristensen et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Critical Role of AKT Protein in Myeloma-induced Osteoclast Formation and Osteolysis
- (2013) Huiling Cao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- BM mesenchymal stromal cell–derived exosomes facilitate multiple myeloma progression
- (2013) Aldo M. Roccaro et al. JOURNAL OF CLINICAL INVESTIGATION
- Programmed Death Receptor-1/Programmed Death Receptor Ligand-1 Blockade after Transient Lymphodepletion To Treat Myeloma
- (2013) T. J. Kearl et al. JOURNAL OF IMMUNOLOGY
- Myeloid-Derived Suppressor Cells Regulate Growth of Multiple Myeloma by Inhibiting T Cells in Bone Marrow
- (2013) I. R. Ramachandran et al. JOURNAL OF IMMUNOLOGY
- CS1-specific chimeric antigen receptor (CAR)-engineered natural killer cells enhance in vitro and in vivo antitumor activity against human multiple myeloma
- (2013) J Chu et al. LEUKEMIA
- Influence of Body Mass Index on Survival in Veterans With Multiple Myeloma
- (2013) T. S. Beason et al. ONCOLOGIST
- Delaying skeletal-related events in a randomized phase 3 study of denosumab versus zoledronic acid in patients with advanced cancer: an analysis of data from patients with solid tumors
- (2013) David Henry et al. SUPPORTIVE CARE IN CANCER
- Novel Adipokines and Bone Metabolism
- (2013) Yuan Liu et al. International Journal of Endocrinology
- Long-term survival in multiple myeloma is associated with a distinct immunological profile, which includes proliferative cytotoxic T-cell clones and a favourable Treg/Th17 balance
- (2013) C Bryant et al. Blood Cancer Journal
- Mesenchymal stem cells inhibit multiple myeloma cells via the Fas/Fas ligand pathway
- (2013) Ikiru Atsuta et al. Stem Cell Research & Therapy
- Multiple Myeloma Macrophages: Pivotal Players in the Tumor Microenvironment
- (2013) Simona Berardi et al. Journal of Oncology
- The multifaceted exosome: Biogenesis, role in normal and aberrant cellular function, and frontiers for pharmacological and biomarker opportunities
- (2012) Saumya Pant et al. BIOCHEMICAL PHARMACOLOGY
- Myeloma as a model for the process of metastasis: implications for therapy
- (2012) I. M. Ghobrial BLOOD
- The frequency of T regulatory cells modulates the survival of multiple myeloma patients: detailed characterisation of immune status in multiple myeloma
- (2012) K Giannopoulos et al. BRITISH JOURNAL OF CANCER
- Macrophages and mesenchymal stromal cells support survival and proliferation of multiple myeloma cells
- (2012) Jaehyup Kim et al. BRITISH JOURNAL OF HAEMATOLOGY
- Lenalidomide enhances anti-myeloma cellular immunity
- (2012) Katarina Luptakova et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Marrow Fat and the Bone Microenvironment: Developmental, Functional, and Pathological Implications
- (2012) Clifford J. Rosen et al. CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION
- Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: A combined analysis of 3 pivotal, randomised, phase 3 trials
- (2012) Allan Lipton et al. EUROPEAN JOURNAL OF CANCER
- Extramedullary disease portends poor prognosis in multiple myeloma and is over-represented in high-risk disease even in the era of novel agents
- (2012) S. Z. Usmani et al. HAEMATOLOGICA
- Natural killer cell lines preferentially kill clonogenic multiple myeloma cells and decrease myeloma engraftment in a bioluminescent xenograft mouse model
- (2012) B. E. Swift et al. HAEMATOLOGICA
- T-cell-independent Antitumor Effects of CD40 Ligation
- (2012) Alexander L. Rakhmilevich et al. INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Therapeutic effects of intrabone and systemic mesenchymal stem cell cytotherapy on myeloma bone disease and tumor growth
- (2012) Xin Li et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Multiple myeloma induces the immunosuppressive capacity of distinct myeloid-derived suppressor cell subpopulations in the bone marrow
- (2012) E Van Valckenborgh et al. LEUKEMIA
- Increased osteocyte death in multiple myeloma patients: role in myeloma-induced osteoclast formation
- (2012) N Giuliani et al. LEUKEMIA
- Tumour Cell Generation of Inducible Regulatory T-Cells in Multiple Myeloma Is Contact-Dependent and Antigen-Presenting Cell-Independent
- (2012) Sylvia Feyler et al. PLoS One
- Differential macrophage programming in the tumor microenvironment
- (2012) Brian Ruffell et al. TRENDS IN IMMUNOLOGY
- Impairment in Immunomodulatory Function of Mesenchymal Stem Cells from Multiple Myeloma Patients
- (2011) Bingzong Li et al. ARCHIVES OF MEDICAL RESEARCH
- Immunosuppressive Effects of Multiple Myeloma Are Overcome by PD-L1 Blockade
- (2011) William H.D. Hallett et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Host-derived adiponectin is tumor-suppressive and a novel therapeutic target for multiple myeloma and the associated bone disease
- (2011) J. A. Fowler et al. BLOOD
- Novel epitope evoking CD138 antigen-specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders
- (2011) Jooeun Bae et al. BRITISH JOURNAL OF HAEMATOLOGY
- Myeloid cell diversification and complexity: an old concept with new turns in oncology
- (2011) Mariacristina Chioda et al. CANCER AND METASTASIS REVIEWS
- Multiple Myeloma Mesenchymal Stem Cells: Characterization, Origin, and Tumor-Promoting Effects
- (2011) M. R. Reagan et al. CLINICAL CANCER RESEARCH
- Immature dendritic cells from patients with multiple myeloma are prone to osteoclast differentiation in vitro
- (2011) Marco Tucci et al. EXPERIMENTAL HEMATOLOGY
- Bone remodelling at a glance
- (2011) J. C. Crockett et al. JOURNAL OF CELL SCIENCE
- Soft-Tissue Plasmacytomas in Multiple Myeloma: Incidence, Mechanisms of Extramedullary Spread, and Treatment Approach
- (2011) Joan Bladé et al. JOURNAL OF CLINICAL ONCOLOGY
- Randomized, Double-Blind Study of Denosumab Versus Zoledronic Acid in the Treatment of Bone Metastases in Patients With Advanced Cancer (Excluding Breast and Prostate Cancer) or Multiple Myeloma
- (2011) David H. Henry et al. JOURNAL OF CLINICAL ONCOLOGY
- PD-1 Blockade by CT-011, Anti-PD-1 Antibody, Enhances Ex Vivo T-cell Responses to Autologous Dendritic Cell/Myeloma Fusion Vaccine
- (2011) Jacalyn Rosenblatt et al. JOURNAL OF IMMUNOTHERAPY
- Bone marrow stromal cells protect myeloma cells from bortezomib induced apoptosis by suppressing microRNA-15a expression
- (2011) Mu Hao et al. LEUKEMIA & LYMPHOMA
- The secreted factors responsible for pre-metastatic niche formation: Old sayings and new thoughts
- (2011) Héctor Peinado et al. SEMINARS IN CANCER BIOLOGY
- Monoclonal gammopathy of undetermined significance and risk of skeletal fractures: a population-based study
- (2010) S. Y. Kristinsson et al. BLOOD
- The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti-PD-1 antibody
- (2010) D. M. Benson et al. BLOOD
- Multiple myeloma: biology of the disease
- (2010) Anuj Mahindra et al. BLOOD REVIEWS
- Osteoblast function in myeloma
- (2010) G. David Roodman BONE
- Targeting the bone microenvironment in multiple myeloma
- (2010) G. David Roodman JOURNAL OF BONE AND MINERAL METABOLISM
- Survivin is upregulated in myeloma cell lines cocultured with mesenchymal stem cells
- (2010) Xiaofang Wang et al. LEUKEMIA RESEARCH
- Osteocyte Wnt/ -Catenin Signaling Is Required for Normal Bone Homeostasis
- (2010) I. Kramer et al. MOLECULAR AND CELLULAR BIOLOGY
- Adhesion molecules—The lifelines of multiple myeloma cells
- (2010) Ben-Zion Katz SEMINARS IN CANCER BIOLOGY
- Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1003 consecutive patients
- (2009) M. Varettoni et al. ANNALS OF ONCOLOGY
- Alterations in the antigen processing-presenting machinery of transformed plasma cells are associated with reduced recognition by CD8+ T cells and characterize the progression of MGUS to multiple myeloma
- (2009) V. Racanelli et al. BLOOD
- Anti-DKK1 mAb (BHQ880) as a potential therapeutic agent for multiple myeloma
- (2009) M. Fulciniti et al. BLOOD
- Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis
- (2009) Y. Zheng et al. BLOOD
- Functional Interaction of Plasmacytoid Dendritic Cells with Multiple Myeloma Cells: A Therapeutic Target
- (2009) Dharminder Chauhan et al. CANCER CELL
- Regulatory T Cells: Major Players in the Tumor Microenvironment
- (2009) Marc Beyer et al. CURRENT PHARMACEUTICAL DESIGN
- Cancer associated fibroblasts (CAFs) in tumor microenvironment
- (2009) Fei Xing Frontiers in Bioscience-Landmark
- Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo
- (2009) Anke J Roelofs et al. JOURNAL OF BONE AND MINERAL RESEARCH
- HYD1-induced increase in reactive oxygen species leads to autophagy and necrotic cell death in multiple myeloma cells
- (2009) R. R. Nair et al. MOLECULAR CANCER THERAPEUTICS
- Role of decorin in the antimyeloma effects of osteoblasts
- (2008) X. Li et al. BLOOD
- Pleiotrophin produced by multiple myeloma induces transdifferentiation of monocytes into vascular endothelial cells: a novel mechanism of tumor-induced vasculogenesis
- (2008) H. Chen et al. BLOOD
- The pathogenesis of the bone disease of multiple myeloma
- (2008) Claire M. Edwards et al. BONE
- The Bone Marrow Microenvironment as a Tumor Sanctuary and Contributor to Drug Resistance
- (2008) M. B. Meads et al. CLINICAL CANCER RESEARCH
- Metastases and multiple myeloma generate distinct transcriptional footprints in osteocytesin vivo
- (2008) S Eisenberger et al. JOURNAL OF PATHOLOGY
- Mast Cells Contribute to Vasculogenic Mimicry in Multiple Myeloma
- (2008) Beatrice Nico et al. STEM CELLS AND DEVELOPMENT
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now